Emil Lou

53PUBLICATIONS

293CO-AUTHORS

Molecular targetsPredictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (53)

Sort by Publication Date:

|Jul 11, 2026

Genomic analysis of oesophageal carcinoma (EC) identifies recurrent mutations in histone methyltransferases as a distinctive subset.

|Jul 10, 2026

Activation of the endocytosis pathway stratifies subtypes and therapeutic sensitivity in colorectal cancer.

|Apr 08, 2026

CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancer.

Sepideh Gholami, Anwaar Saeed, Yasmine Baca

|Jan 24, 2026

CISH, a key intracellular checkpoint, in comparison and combination to existing and emerging cancer immune checkpoints.

Florencia Cano, Alberto Bravo-Blas, Mathilde Colombe

|Dec 30, 2025

Real-World Impact of Metformin on Outcomes in Patients with Deficient DNA Mismatch Repair and Microsatellite Instability (dMMR/MSI) Colorectal Cancer Treated with Immune Checkpoint Inhibitors.

Garima Gupta, Negar Sadeghipour, Fuat Bicer

|Dec 21, 2025

Clinical and molecular characterization of <i>AXL</i> in colorectal cancer, CALGB (Alliance)/SWOG 80405 and real-world data.

Karam Ashouri, Joshua Millstein, Yan Yang

Pageof 9

Frequent Collaborators

11 joint publications

Heinz-Josef Lenz

Andrew Elliott

Sanjay Goel

Anthony F Shields

W Michael Korn

Moh'd M Khushman

John Marshall

Justin Hwang

Joanne Xiu

Richard M Goldberg

Frequent Collaborators

11 joint publications

Heinz-Josef Lenz

8 joint publications

Andrew Elliott

7 joint publications

Sanjay Goel

7 joint publications

Anthony F Shields